Centre Hospitalier Eure-seine

This study looks at whether giving low-risk blood clot patients a 4G tablet for remote check-ups, education, and questionnaires is practical and satisfying for patients and doctors. Fifty participants will use the tablet for up to a year while following standard treatment. The go…